EJNMMI Radiopharmacy and Chemistry

Scope & Guideline

Innovating the synthesis and application of radiopharmaceuticals.

Introduction

Delve into the academic richness of EJNMMI Radiopharmacy and Chemistry with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN-
PublisherSPRINGERNATURE
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationEJNMMI RADIOPHARM CH / EJNMMI Radiopharm. Chem.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND

Aims and Scopes

EJNMMI Radiopharmacy and Chemistry focuses on advancing the field of radiopharmacy and radiochemistry through innovative research and development in radiopharmaceuticals. The journal emphasizes the intersection of chemistry and nuclear medicine, highlighting methodologies that enhance the efficacy and safety of radiopharmaceuticals for diagnostic and therapeutic applications.
  1. Radiopharmaceutical Development:
    The journal publishes research on the synthesis, characterization, and evaluation of new radiopharmaceuticals, focusing on their potential applications in imaging and therapy.
  2. Automated Radiosynthesis:
    A significant emphasis is placed on automated synthesis techniques that improve the production efficiency and reproducibility of radiopharmaceuticals, ensuring compliance with GMP standards.
  3. Theranostic Applications:
    Research articles often explore theranostic approaches that combine diagnostic imaging and targeted therapy, particularly in oncology, using radiolabeled compounds.
  4. Quality Control and Regulatory Compliance:
    The journal addresses best practices in quality control and regulatory frameworks for the production of radiopharmaceuticals, ensuring safety and efficacy in clinical settings.
  5. Innovative Imaging Techniques:
    There is a consistent focus on novel imaging methods and probes, including PET and SPECT, aimed at enhancing the diagnostic capabilities in various medical conditions, particularly cancer.
Recent publications in EJNMMI Radiopharmacy and Chemistry indicate a shift towards several trending and emerging themes, reflecting the current priorities and innovations in the field of radiopharmacy.
  1. Precision Medicine and Targeted Therapies:
    There is a growing emphasis on developing radiopharmaceuticals that are tailored for specific patient populations and disease types, particularly in cancer therapies, showcasing the trend towards personalized medicine.
  2. Novel Radiometals and Radionuclides:
    Research focusing on the use of new radiometals and radionuclides for imaging and therapeutic applications is on the rise, indicating a shift towards exploring alternatives to established isotopes.
  3. Microfluidics and Automated Production Techniques:
    Innovations in microfluidic systems for the production of radiopharmaceuticals are emerging as a key trend, enhancing the efficiency and scalability of radiotracer synthesis.
  4. Biodistribution and Pharmacokinetics Studies:
    An increased focus on understanding the biodistribution and pharmacokinetics of radiopharmaceuticals is evident, which is crucial for optimizing their clinical applications and improving safety profiles.
  5. Regulatory Frameworks and Patient Access:
    Research addressing the regulatory landscape and strategies to enhance patient access to radiopharmaceuticals is gaining traction, reflecting the importance of policy in the advancement of the field.

Declining or Waning

As the field of radiopharmacy evolves, certain research themes appear to be declining in prominence within the journal. This section highlights those areas that have seen a reduced focus over recent publications.
  1. Conventional Radiopharmaceuticals:
    Research on traditional radiopharmaceuticals is becoming less frequent, as the field shifts towards more advanced and specific targeting agents, particularly in oncology.
  2. Basic Radiochemistry Techniques:
    While foundational radiochemistry methods remain important, there is a noticeable decline in publications focused solely on basic synthesis techniques without innovative applications or improvements.
  3. Generalized Quality Control Practices:
    There is a trend away from generic quality control discussions, as the journal increasingly emphasizes specific and novel methodologies tailored to particular radiopharmaceuticals.

Similar Journals

Molecular Imaging and Radionuclide Therapy

Empowering knowledge in imaging and therapeutic advancements.
Publisher: GALENOS PUBL HOUSEISSN: 2146-1414Frequency: 3 issues/year

Molecular Imaging and Radionuclide Therapy is an esteemed academic journal published by GALENOS PUBL HOUSE, dedicated to advancing the fields of radiology, nuclear medicine, and imaging. Since its inception, this Open Access journal has facilitated the dissemination of high-quality research and innovative practices in molecular imaging and radionuclide therapy, making it a vital resource for researchers, professionals, and students alike. With an ISSN of 2146-1414 and an E-ISSN of 2147-1959, the journal has established its presence globally while specifically catering to the Turkish academic and medical community. As of 2023, it is ranked #241/333 in the Radiology, Nuclear Medicine and Imaging category on Scopus, holding a respectable Q3 quartile ranking. The journal serves as a platform for sharing impactful findings from 2017 to 2024, reinforcing its commitment to open access since 2011. With a dedication to enhancing the knowledge base in molecular imaging and therapy, it remains an important conduit for scholarly communication and collaborative research developments in this dynamic field.

CANCER IMAGING

Exploring New Horizons in Cancer Diagnostics
Publisher: BMCISSN: 1740-5025Frequency: 1 issue/year

CANCER IMAGING, published by BMC, stands as a leading open-access journal in the realms of oncology and medical imaging, significantly contributing to the advancement of cancer research since its inception in 2000. With an impressive impact across multiple domains—most notably ranking Q1 in prestigious categories such as Medicine (miscellaneous), Oncology, and Radiology—this journal ensures high visibility and influence within the academic community. As of 2023, it is recognized in various Scopus rankings, securing top positions in the fields of Radiology, Nuclear Medicine, and Imaging, alongside Radiological and Ultrasound Technology. The journal's commitment to open-access publication, adopted in 2014, enhances accessibility for researchers, healthcare professionals, and students alike, fostering an inclusive environment for sharing critical advancements and innovative methodologies in cancer imaging. Set in the vibrant landscape of the United Kingdom, CANCER IMAGING continues to play a vital role in elucidating the complexities of cancer diagnostics and treatment, establishing itself as an essential resource for those pursuing excellence in cancer care and research.

INVESTIGATIVE RADIOLOGY

Exploring the Depths of Diagnostic Imaging
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0020-9996Frequency: 12 issues/year

INVESTIGATIVE RADIOLOGY, published by Lippincott Williams & Wilkins, is a premier peer-reviewed journal dedicated to disseminating innovative research in the fields of radiology, nuclear medicine, and imaging. With a notable impact factor underscored by its impressive ranking—10th out of 333 in its category, positioning it within the 97th percentile—this journal serves as a vital resource for researchers, professionals, and students eager to stay at the forefront of advancements from 1966 to 2024. Although it does not offer open access, the high-quality studies and reviews found within its pages contribute significantly to the understanding and application of modern imaging techniques. Recognized for its Q1 status in both miscellaneous medicine and radiology specializations, INVESTIGATIVE RADIOLOGY continues to play an essential role in shaping the future of diagnostic and therapeutic imaging.

EUROPEAN JOURNAL OF RADIOLOGY

Transforming Patient Care Through Radiological Research
Publisher: ELSEVIER IRELAND LTDISSN: 0720-048XFrequency: 12 issues/year

The European Journal of Radiology, published by Elsevier Ireland Ltd, is a premier peer-reviewed journal in the fields of radiology, nuclear medicine, and imaging. Established in 1981, it has carved a significant niche within the academic community, showcasing innovative research that enhances medical imaging practices and improves patient care. With an impressive ranking in the Q1 category for both Medicine (miscellaneous) and Radiology, Nuclear Medicine, and Imaging in 2023, the journal is recognized globally for its commitment to advancing scientific knowledge and improving imaging methodologies. The journal's Scopus ranking of #60/333, placing it in the 82nd percentile, underlines its reputation for high-quality research and scholarly contributions. While traditionally a subscription-based journal, it continually evolves to meet the demands of the academic landscape, aiming to bridge the gap between research and clinical practice. Researchers, healthcare professionals, and students alike can benefit from exploring its extensive archives and current publications, which are curated to foster education and innovation in the medical imaging domain.

American Journal of Nuclear Medicine and Molecular Imaging

Advancing the Frontiers of Nuclear Medicine and Imaging
Publisher: E-CENTURY PUBLISHING CORPISSN: 2160-8407Frequency: 6 issues/year

The American Journal of Nuclear Medicine and Molecular Imaging (ISSN: 2160-8407), published by E-CENTURY PUBLISHING CORP, is a distinguished platform for the dissemination of cutting-edge research in the fields of nuclear medicine and molecular imaging. With a commitment to advancing scientific inquiry and clinical applications, this journal serves as a vital resource for researchers, clinicians, and students dedicated to exploring innovative imaging modalities, radiopharmaceuticals, and their applications in diagnosing and treating various medical conditions. Although currently not available as an open-access journal, this publication plays a crucial role in fostering academic dialogue and collaboration within the medical community. Its diverse range of topics and expert contributions underscore its impact in bridging the gap between research findings and clinical practice, making it an essential read for anyone interested in the rapidly evolving landscape of nuclear medicine and imaging technologies.

QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Pioneering Insights into the Future of Medical Imaging.
Publisher: EDIZIONI MINERVA MEDICAISSN: 1824-4785Frequency: 4 issues/year

The Quarterly Journal of Nuclear Medicine and Molecular Imaging, published by Edizioni Minerva Medica in Italy, serves as a pivotal platform for researchers and practitioners in the fields of Nuclear Medicine and Molecular Imaging. With an ISSN of 1824-4785 and an E-ISSN of 1827-1936, this journal boasts a respectable impact factor and is positioned in the Q3 quartile of the Radiology, Nuclear Medicine and Imaging category, based on the latest 2023 evaluations. As the journal continues to converge from its inception in 2004 to its anticipated expansions through 2024, it aims to disseminate high-quality, peer-reviewed articles that advance the frontier of imaging technologies and their applications in clinical practice. Researchers, professionals, and students are encouraged to contribute to its diverse scope, which encompasses innovative research, clinical findings, and reviews that encapsulate cutting-edge advancements in the field, highlighting its importance as an essential resource for knowledge and collaboration.

NUCLEAR MEDICINE COMMUNICATIONS

Exploring the Depths of Nuclear Medicine Research
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0143-3636Frequency: 12 issues/year

NUCLEAR MEDICINE COMMUNICATIONS is a prestigious academic journal published by Lippincott Williams & Wilkins, focusing on the multifaceted field of nuclear medicine and its applications in diagnostics and therapy. With a solid history spanning from 1980 to 2024, this journal provides a platform for peer-reviewed research articles, clinical studies, and innovative techniques that enrich the knowledge base within the fields of {{medicinal applications, patient care, and imaging technology}}. Currently classified in the Q3 quartile for both Medicine (Miscellaneous) and Radiology, Nuclear Medicine, and Imaging, the journal reflects its commitment to advancing healthcare practices. Although it does not offer open access options, its accessibility through reputable institutions promotes scholarly exchange among researchers, professionals, and students alike. The critical insights provided in NUCLEAR MEDICINE COMMUNICATIONS are essential for those dedicated to enhancing patient outcomes through cutting-edge nuclear medical technologies.

JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY

Exploring the depths of radioanalytical research.
Publisher: SPRINGERISSN: 0236-5731Frequency: 12 issues/year

JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY, published by Springer, serves as a vital platform for the dissemination of research in the fields of analytical chemistry, nuclear science, and radiochemistry. With an ISSN of 0236-5731 and an E-ISSN of 1588-2780, this journal has been a beacon of innovation and scholarly communication since its inception, transitioning from converged years of 1977-1979 to its current continuity from 1984 to 2024. Positioned in the Q3 category for analytical chemistry and other related fields such as health, toxicology, and nuclear engineering, it boasts significant standings in the Scopus rankings, reflecting its relevance and impact within these disciplines. The journal emphasizes open access, encouraging broader accessibility to quality research, which is critical for students, professionals, and ongoing global scientific discussions. As a leader in its domain, the JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY is committed to advancing the understanding of radioactive materials, environmental safety, and health applications, ensuring its readers remain at the forefront of emerging trends and discoveries.

BMC MEDICAL IMAGING

Shaping Tomorrow's Imaging Solutions for Better Patient Care.
Publisher: BMCISSN: 1471-2342Frequency: 1 issue/year

BMC Medical Imaging is a premier open-access journal dedicated to advancing the field of radiology, nuclear medicine, and imaging technologies. Published by BMC in the United Kingdom, this journal serves as a vital resource for researchers, clinicians, and students, fostering a collaborative environment for sharing innovative findings and methodologies in medical imaging. With a commendable impact factor and an impressive Scopus ranking within the top 35% of its category, BMC Medical Imaging provides a platform for high-quality research to be disseminated widely and freely since its inception in 2001. The journal aims to cover a diverse array of topics, from advanced imaging techniques to their clinical applications, enhancing the understanding and effectiveness of diagnostic practices. By contributing to the body of knowledge and facilitating open access to research, BMC Medical Imaging plays a pivotal role in shaping the future of medical imaging and improving patient care.

JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY

Enhancing Radiology with Cutting-Edge Research
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0363-8715Frequency: 6 issues/year

JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, published by Lippincott Williams & Wilkins, stands as a vital resource in the field of Radiology, Nuclear Medicine, and Imaging. Since its inception in 1977, this journal has been dedicated to advancing the understanding and application of computer-assisted tomography, emphasizing innovative research and clinical practices that enhance diagnostic imaging techniques. With an impact factor reflective of its rigorous scholarship and relevance—ranking in the Q3 category—the journal serves as an essential platform for contributors and readers alike, navigating the challenges and opportunities within a rapidly evolving field. Researchers, professionals, and students are encouraged to engage with the rich repository of articles that cover emerging technologies, clinical applications, and theoretical advancements, collectively fostering a deeper comprehension of imaging sciences. Although not currently designated as an open-access journal, it continues to enhance discourse in the community from its headquarters in Philadelphia, PA, maintaining a commitment to the highest standards of academic excellence.